Down syndrome patients benefit from a new therapy that increases cognition

Down syndrome patients benefit from a new therapy that increases cognition ...

Down syndrome (DS) is caused by a trisomy of chromosome 21, including intellectual impairment and olfactory impairment.

A team from the Lille Neuroscience & Cognition laboratory (Inserm/Université de Lille, Lille University Hospital) has col ...

Read more in the source

You may also like: